Quadrivalent Antibody
This product boasts unique production processes, easier strain updates, wider coverage, higher oral absorption rate, better stability, enhanced safety, and more significant clinical efficacy.





I. Product Overview This product is a set of functional immunoglobulins expressed via genetic recombination technology. These immunoglobulins cover various prevalent viral strains in China, including all types of avian adenovirus, Newcastle disease virus, influenza virus subtype H9, as well as classical and variant strains of infectious bursal disease virus. Compared with the yolk antibodies commonly used in the market, this product boasts unique production processes, easier strain updates, wider coverage, higher oral absorption rate, better stability, enhanced safety, and more significant clinical efficacy. II. Main Ingredients Genetically recombinant immunoglobulins, taurine, etc. III. Product Features (I) Quadrivalent Targeting for Precise Protection Exclusively integrating four core immunoglobulins, it adopts the innovative quadrivalent immune protein complex technology to simultaneously prevent and control four major threats: avian adenovirus, Newcastle disease, influenza H9, and variant strains of infectious bursal disease. It targets and eliminates viruses, reduces the risk of mixed infections, and truly achieves "one dose for multiple protections". Adenovirus genetically recombinant protein – Covers all currently prevalent pathogenic strains (Group I, Types C, D, E), and effectively prevents and controls pericardial effusion, inclusion body hepatitis, gizzard erosion, and ulceration. Newcastle disease genetically recombinant protein – Covers Newcastle disease virus Genotype II and Genotype VII, and effectively prevents and controls Newcastle disease in chickens, as well as paramyxovirus in ducks and geese. Influenza H9 genetically recombinant protein – Effectively blocks respiratory issues, mixed infections, and decreased immunity caused by widespread influenza H9 infection. Infectious bursal disease genetically recombinant protein – Overcomes variant strains and addresses immune suppression, low feed intake, and high mortality rates caused by latent infectious bursal disease virus infection.